exRNAdisease

Entry Detail

---



General Information

Database ID: exR0763214 RNA Name: RPS9 RNA Type: mRNA Chromosome: chr19 Starnd: + Coordinate: Start Site(bp): 54200809 End Site(bp): 54249003 External Links: ENSG00000170889

Disease Information

Disease Name: Glioblastoma Multiforme Disease Category: Cancers MeSH ID: D005909 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell

Expression Detail

GEO ID: GSE106804 Description: Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles Experimental Design: Cancer vs Control Case Disease Type: Glioblastoma Multiforme Case Disease SubType: NA Case Sample: Glioblastoma Multiforme Control Sample: Healthy Number of Case: 13 Number of Control: 6 Number of Samples: 19

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand ADRM1 chr20 62302093 62308862 + AL021546.1 chr12 120438198 120460006 + ALDH16A1 chr19 49453225 49471050 + AC007192.1 chr19 18153158 18178117 + AHSA1 chr14 77457870 77469472 + ADGRG5 chr16 57542643 57591681 + AGAP4 chr10 45825594 45853875 - AC105052.3 chr7 102637049 102671641 - ABRACL chr6 139028745 139043302 + ADAM8 chr10 133262420 133276868 - AGGF1 chr5 77029251 77065234 + ADAM10 chr15 58588809 58749791 - ACTB chr7 5527148 5563784 - AKT1S1 chr19 49869033 49878459 - AC004922.1 chr7 99325879 99394653 + ACAA2 chr18 49782164 49813953 - AC120057.2 chr17 7240427 7244635 - AHCY chr20 34280268 34311802 - ACVR2B chr3 38453890 38493142 + AASDHPPT chr11 106075501 106098699 + ACER3 chr11 76860867 77026797 + ACOT2 chr14 73567620 73575658 + AC245033.1 chr15 82536788 82573194 - ABLIM1 chr10 114431113 114768061 - AC138811.2 chr16 18788063 18801519 - ADNP chr20 50888916 50931437 - AFDN chr6 167826922 167972023 + ABHD17B chr9 71862452 71910931 - AKNA chr9 114334156 114394405 - ACTG1 chr17 81509971 81523847 - miRNA targets: miRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa-miR-3615 chr17 74748663 74748683 + hsa-miR-4707-5p chr14 22956998 22957020 - circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC004069.1 chr4 105137280 105140619 - AC022400.3 chr10 73674295 73730466 - AC073508.3 chr17 40648300 40649718 + AC132217.1 chr11 2129121 2129964 - AC245014.3 chr1 145281116 145281462 + AD000090.1 chr19 35557956 35581954 + AL139089.1 chr13 52651305 52652279 - Display:

Experiment Detail

GEO ID: NA Sample Source: NA Source Fraction: NA Platform: NA Method: NA Num of detected RNA Type: NA Num of detected RNAs of this Type: NA Sample treatment protocol: NA RNA Extract protocol: NA RNA library preparation protocol: NA

Reference

PMID: 29330365 Title: Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles. Author: Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL. Journal: Nat Commun. 2018 Jan 12;9(1):175. Description: Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.